Brief: LogicBio Therapeutics Receives Compliance Letter From Nasdaq
20/10/2022 22:56
Oct 20 (Reuters) - LogicBio Therapeutics Inc LOGC.O :
* LOGICBIO THERAPEUTICS INC - ON OCT 14, CO RECEIVED
COMPLIANCE
LETTER FROM NASDAQ NOTIFYING THAT CO’S BID PRICE DEFICIENCY HAD
BEEN CURED
Source (https://bit.ly/3VIfwlb)
Further company coverage: LOGC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ContextLogic Holdings
See all newsContextLogic Holdings Q2 revenue flat as higher prices offset lower volumes
Brief: ContextLogic Holdings Q2 Adjusted EBITDA USD 10.8 Million
ContextLogic Holdings Q1 net income jumps on tax benefit
Brief: ContextLogic Holdings Q1 Net Income USD 17 Million
Brief: Contextlogic To Acquire US Salt From Emerald Lake In $907.5 Million Transaction, Creating New Business Ownership Platform In Partnership With Abrams Capital And BC Partners Credit